- CRS Publications
- News
News
Authors:
Date:
PRNewswire: August 18, 2017 – WASHINGTON, DC, U.S.A. – An article published in Experimental Biology and Medicine (volume 242, issue 14, August 2017) reports that a plant virus–based system can be used to deliver anticancer drugs. The study, led by Dr. Nicole Steinmetz in the Department of…
Authors:
Date:
PRNewswire: August 15, 2017 – PISCATAWAY, NJ, U.S.A. – PuraCap® Pharmaceutical today introduced the EpiCeram® controlled release skin barrier emulsion quad pack, which contains 400 g of eczema relief. EpiCeram® is an FDA-approved topical prescription emollient used to treat dry skin conditions and…
Authors:
Date:
Business Wire: August 14, 2017 – NEW YORK, NY, U.S.A. – PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended June 30, 2017, and provided a business update.
“During this past quarter and…
Authors:
Date:
Business Wire: August 8, 2017 – CHANDLER, AZ, U.S.A. – The Arizona Bioindustry Association will honor Marvin J. Slepian, M.D., of the University of Arizona with the AZBio Pioneer Award for Lifetime Achievement at the 2017 AZBio Awards. Arizona life science and business leaders, as well as guests…
Date:
Business Wire: August 7, 2017 – JERUSALEM, Israel – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the…
Authors:
Date:
PRNewswire: July 31, 2017 – DUBLIN, Ireland – Perrigo Company plc (NYSE; TASE: PRGO) and its co-development partner Aveva Drug Delivery Systems, Inc., an Apotex Company, today announced the prescription pharmaceutical launch of scopolamine 1.5 mg transdermal system patch, the AB rated generic…
